ClinicalTrials.Veeva

Menu

Identification of Pathogens in the Neonatal Intensive Care Unit (NICU)

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Pathogen Resistance

Treatments

Other: Laboratory identification of positive cultures

Study type

Observational

Funder types

Other

Identifiers

NCT03077100
HYMC-0001-17

Details and patient eligibility

About

To aim of this study is to identify the pathogens and their distribution in the NICU and to determine whether empirical antibiotics are suitable for the treatment of sepsis in the unit.

Enrollment

2,000 estimated patients

Sex

All

Ages

Under 3 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newborns with positive cultures

Exclusion criteria

Trial design

2,000 participants in 1 patient group

Newborns with positive cultures
Description:
Positive cultures of newborns hospitalized in the NICU in the past 5 years will undergo laboratory examination and identification
Treatment:
Other: Laboratory identification of positive cultures

Trial contacts and locations

1

Loading...

Central trial contact

Samah Abu-Fanni, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems